{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:39:53Z","timestamp":1789011593457,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","bbmt.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.bbmt.2019.04.015","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T13:43:11Z","timestamp":1555508591000},"page":"1642-1647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Severe Herpes Zoster Requiring Intravenous Antiviral Treatment in Allogeneic Hematopoietic Cell Transplantation Recipients on Standard Acyclovir Prophylaxis"],"prefix":"10.1016","volume":"25","author":[{"given":"Emily","family":"Baumrin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjat","family":"Kanjilal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent T.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas C.","family":"Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey R.","family":"Baden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2019.04.015_bib0001","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1083-8791(00)70051-6","article-title":"Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome","volume":"6","author":"Koc","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0002","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1399-0012.2008.00877.x","article-title":"Clinical efficacy of prophylactic strategy of long-term low-dose acyclovir for varicella-zoster virus infection after allogeneic peripheral blood stem cell transplantation","volume":"22","author":"Kim","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0003","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1399-3062.2007.00247.x","article-title":"Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders","volume":"10","author":"Kim","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0004","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/infdis\/152.6.1172","article-title":"Infection with varicella-zoster virus after marrow transplantation","volume":"152","author":"Locksley","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0005","series-title":"Thomas\u2019 Hematopoietic Cell Transplantation: Stem Cell Transplantation","first-page":"1046","article-title":"Varicella zoster virus infections","author":"Ho","year":"2016"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0006","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/sj.bmt.1701796","article-title":"Herpes zoster ophthalmicus following bone marrow transplantation in children","volume":"23","author":"Walton","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0007","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1572-0241.1998.230_a.x","article-title":"Visceral varicella-zoster after bone marrow transplantation: report of a case series and review of the literature","volume":"93","author":"David","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0008","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.bmt.1702599","article-title":"Varicella zoster meningoencephalitis following treatment for dermatomal zoster in an alloBMT patient","volume":"26","author":"Tauro","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0009","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2169\/internalmedicine.43.861","article-title":"Involvement of the esophagus and stomach as a first manifestation of varicella zoster virus infection after allogeneic bone marrow transplantation","volume":"43","author":"Takatoku","year":"2004","journal-title":"Intern Med"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0010","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/tid.12073","article-title":"Visceral varicella zoster virus infection after allogeneic stem cell transplantation","volume":"15","author":"Doki","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0011","first-page":"277","article-title":"Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications","volume":"13","author":"Han","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0012","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1182\/blood-2005-09-3624","article-title":"Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation: a randomized double-blind placebo-controlled study","volume":"107","author":"Boeckh","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0013","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood-2007-03-077644","article-title":"One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation","volume":"110","author":"Erard","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0014","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ajh.21152","article-title":"Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation","volume":"83","author":"Asano-Mori","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0015","first-page":"185","article-title":"Long-term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro","volume":"1","author":"Ljungman","year":"1986","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0016","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/bjc.1989.88","article-title":"The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation","volume":"59","author":"Selby","year":"1989","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0017","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/sj.bmt.1704959","article-title":"The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation","volume":"35","author":"Thomson","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0018","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/sj.bmt.1703214","article-title":"Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation","volume":"28","author":"Kanda","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0019","first-page":"99","article-title":"Prevention of herpes zoster in patients by long-term oral acyclovir after allogeneic bone marrow transplantation","volume":"85","author":"Perren","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0020","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1016\/j.ejca.2009.08.010","article-title":"Antiviral prophylaxis in haematological patients: systematic review and meta-analysis","volume":"45","author":"Yahav","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0021","doi-asserted-by":"crossref","first-page":"882","DOI":"10.6004\/jnccn.2016.0093","article-title":"Prevention and treatment of cancer-related infections, version 2.2016. NCCN Clinical Practice Guidelines in Oncology","volume":"14","author":"Baden","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0022","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/cid\/ciq147","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0023","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.antiviral.2017.01.011","article-title":"Antiviral prophylaxis for preventing herpes zoster in hematopoietic stem cell transplant recipients: a systematic review and meta-analysis","volume":"140","author":"Seo","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0024","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1182\/bloodadvances.2016000836","article-title":"Zoster prophylaxis after allogeneic hematopoietic cell transplantation using acyclovir\/valacyclovir followed by vaccination","volume":"1","author":"Jamani","year":"2016","journal-title":"Blood Adv"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0025","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.bbmt.2010.07.026","article-title":"An international comparison of current strategies to prevent herpesvirus and fungal infections in hematopoietic cell transplant recipients","volume":"17","author":"Pollack","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0026","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.bbmt.2014.06.002","article-title":"Varicella-zoster reactivation after allogeneic stem cell transplantation without routine prophylaxis: the incidence remains high","volume":"20","author":"Blennow","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0027","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.bbmt.2013.11.013","article-title":"Live attenuated varicella-zoster vaccine in hematopoietic stem cell transplantation recipients","volume":"20","author":"Issa","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0028","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1182\/blood-2014-04-573048","article-title":"A phase 1\/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients","volume":"124","author":"Stadtmauer","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0029","series-title":"Communication presented at the 44th Annual Meeting of the European Society for Blood and Marrow Transplantation","article-title":"Immunogenicity and safety of an adjuvanted herpes zoster subunit vaccine in adult autologous hematopoietic stem cell transplant recipients: phase 3, randomized, placebo-controlled, ZOE-HSCT clinical trial","author":"Sullivan","year":"2018"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0030","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/S0140-6736(18)30631-7","article-title":"Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Winston","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2019.04.015_bib0031","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/infdis\/jit344","article-title":"Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults","volume":"208","author":"Mullane","year":"2013","journal-title":"J Infect Dis"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119302381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119302381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T20:41:20Z","timestamp":1738010480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879119302381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1083879119302381"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.04.015","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe Herpes Zoster Requiring Intravenous Antiviral Treatment in Allogeneic Hematopoietic Cell Transplantation Recipients on Standard Acyclovir Prophylaxis","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}